A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma.
about
The influence of hepatitis B virus on antiviral treatment with interferon and ribavirin in Asian patients with hepatitis C virus/hepatitis B virus coinfection: a meta-analysisViral hepatitis and hepatocellular carcinomaAntiviral Therapy in Patients with Viral Hepatitis and Hepatocellular Carcinoma: Indications and PrognosisA review of the infection-associated cancers in North African countriesRisk Factors for the Development of Hepatocellular Carcinoma in ThailandEarly-life exposures to infectious agents and later cancer developmentManagement of chronic hepatitis B: Canadian Association for the Study of the Liver consensus guidelinesThe natural history of hepatitis C virus (HCV) infection.Hepatocellular carcinoma: Epidemiology, risk factors and pathogenesisBiological impact of hepatitis B virus X-hepatitis C virus core fusion gene on human hepatocytesModel-guided therapy for hepatocellular carcinoma: a role for information technology in predictive, preventive and personalized medicineRisk behaviors, prevalence of HIV and hepatitis C virus infection and population size of current injection drug users in a China-Myanmar border city: results from a Respondent-Driven Sampling Survey in 2012Comprehensive comparison of three different immunosuppressive regimens for liver transplant patients with hepatocellular carcinoma: steroid-free immunosuppression, induction immunosuppression and standard immunosuppressionEpidemiology of viral hepatitis and hepatocellular carcinomaGlobal epidemiology and burden of HCV infection and HCV-related disease.APASL consensus statements and recommendations for hepatitis C prevention, epidemiology, and laboratory testing.Indian National Association for Study of the Liver (INASL) Guidance for Antiviral Therapy Against HCV Infection in 2015Consensus Statement of HCV Task Force of the Indian National Association for Study of the Liver (INASL). Part II: INASL Recommendations for Management of HCV in India.Hepatitis B vaccinations among Koreans: Results from 2005 Korea National Cancer Screening Survey.Multiplicative synergistic risk of hepatocellular carcinoma development among hepatitis B and C co-infected subjects in HBV endemic area: a community-based cohort study.Cluster of liver cancer and immigration: a geographic analysis of incidence data for Ontario 1998-2002.Eastern Asian expert panel opinion: designing clinical trials of molecular targeted therapy for hepatocellular carcinomaStimulation of inducible nitric oxide by hepatitis B virus transactivator protein HBx requires MTA1 coregulator.Interval to vascularization development in cirrhotic precursor nodules in patients with hepatitis B and C virus co-infectionsProduction and pathogenicity of hepatitis C virus core gene products.Hepatocellular carcinoma prevention: a worldwide emergence between the opulence of developed countries and the economic constraints of developing nations.Oxidative stress and hepatic Nox proteins in chronic hepatitis C and hepatocellular carcinoma.Long-term effect of interferon plus ribavirin on hepatitis B surface antigen seroclearance in patients dually infected with hepatitis B and C viruses.Recent developments in the first detection of hepatocellular carcinomaRising costs and hospital admissions for hepatocellular carcinoma in Portugal (1993-2005).Significance of hepatitis B virus surface antigen, hepatitis C virus expression in hepatocellular carcinoma and pericarcinomatous tissues.Combined effect of socioeconomic status, viral hepatitis, and lifestyles on hepatocelluar carcinoma risk in KoreaHepatocellular carcinoma in the world and the middle East.Fifteen-year population attributable fractions and causal pies of risk factors for newly developed hepatocellular carcinomas in 11,801 men in TaiwanInsulin resistance and steatosis in HBV-HCV co-infected patients: Role of PNPLA3 polymorphisms and impact on liver fibrosis progressionIntra-hepatic and extra-hepatic cholangiocarcinoma: New insight into epidemiology and risk factors.Hepatitis B virus and hepatitis C virus dual infection.Current Concepts of HBV/HCV Coinfection: Coexistence, but Not Necessarily in Harmony.Hepatocellular carcinoma and hepatitis C in the United States.Genetic polymorphisms of epidermal growth factor in relation to risk of hepatocellular carcinoma: two case-control studies.
P2860
Q21245094-91DE7ED1-70A1-4BDC-9CE6-3E0F2E55FBE0Q21245597-9E52102C-E2F4-4788-9E5C-E5807E1F6E09Q26740313-82EFB3B5-C9E1-4BC6-9DB3-6B9336467654Q26741909-0CE35113-4942-41B8-8F0A-B51FBF18375FQ26775650-5D96DD3C-9A30-4595-A75D-A405351188BCQ26786103-7EA4AD2F-C470-430A-87EB-1C04F8785075Q27000080-18BCE5CC-0817-4CCA-BD74-C97477697BF2Q27473116-202A778C-8CE2-455A-9BCC-158B29766D2CQ27489394-4D8225AD-FDFA-4A2D-8BD2-EEC62299FB32Q27489612-E538F7BA-075D-4C13-BBB9-1CEE117100B2Q28087569-77D7017E-5869-4A64-9F6F-8B4534CA21CCQ28542883-AB5B8009-1CB8-455F-8728-6C7EA83E4487Q28545113-6AB36482-CEF0-4A74-ADF0-414379ED6255Q29617918-3C7F797B-AEDC-4B0D-9465-C199352366D3Q30240220-0055BD15-5B65-4019-8CF6-649893AD89E3Q30250088-4034E76A-D8AE-4CE5-979F-446CCDB955E4Q30375305-F7FE8A53-6B0D-4DB1-8127-4612C7A743B3Q30417045-7AAD0E7B-5704-42CB-B0A3-419BFB54C27DQ30908795-1E2BF4A6-5D62-4A91-8873-BD54DBFD3C04Q31102359-45E5F0EB-E041-450C-8B56-AC27002DEAAFQ31157318-B549324C-30A9-47BC-B93B-86B67B3174FDQ33742856-4182758D-F57A-412E-AFD3-4B8ACCEF59BEQ33747940-ABC76BEB-3953-4862-9179-A1FA843C6C1CQ33773121-6F2E68EC-C43A-488D-AB88-48A6B5892E57Q33780095-E7F44CC8-6180-4E4A-BB6C-3734B79F1344Q33866448-2A8E88DE-D32B-46F0-B043-89FA85D3AB84Q33904328-4A74AA6F-A815-4411-85D3-EF125A48DACBQ33939443-E688D0EC-9864-46EB-8059-0B8D7B37C6D2Q34055894-37BBD1CB-2F64-446C-88C0-57111FDBD5E0Q34099104-45707D90-7A9F-4ACC-A93F-1291805371A9Q34112285-96C9E57E-0C10-4829-992D-16F43554EED8Q34122759-20A56D55-B03B-488C-9D91-9A75390F77DCQ34134967-B7EA6FF1-42F7-4F32-95D4-D793B2976260Q34233722-3451C172-2277-4351-99CB-A6C335AFE0B4Q34263370-9A25C175-06F2-40E5-97DA-75AC34175E7AQ34398255-A51F4DB9-EBFB-4994-A859-0703BD0E86A5Q34404975-2D6CC7ED-E80D-407D-BCCD-87503A80E808Q34502980-8B8F2D40-4772-4842-B0BB-BAFB705C80D1Q34528514-D97F6F32-0D93-4FB4-9A8E-FAFA7B7FCC9EQ34590768-91327F4A-E7C0-41FC-BED8-37CFBB04374D
P2860
A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
A meta-analysis of epidemiolog ...... sing hepatocellular carcinoma.
@en
A meta-analysis of epidemiolog ...... sing hepatocellular carcinoma.
@nl
type
label
A meta-analysis of epidemiolog ...... sing hepatocellular carcinoma.
@en
A meta-analysis of epidemiolog ...... sing hepatocellular carcinoma.
@nl
prefLabel
A meta-analysis of epidemiolog ...... sing hepatocellular carcinoma.
@en
A meta-analysis of epidemiolog ...... sing hepatocellular carcinoma.
@nl
P2860
P1476
A meta-analysis of epidemiolog ...... sing hepatocellular carcinoma.
@en
P2093
P2860
P304
P356
10.1002/(SICI)1097-0215(19980130)75:3<347::AID-IJC4>3.0.CO;2-2
P577
1998-01-01T00:00:00Z